pregnenolone has been researched along with androstane-3,17-diol glucuronide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BĂ©langer, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F | 1 |
Acaz-Fonseca, E; Caruso, D; Garcia-Segura, LM; Giatti, S; Lopez-Rodriguez, AB; Melcangi, RC; Spezzano, R; Viveros, MP | 1 |
2 other study(ies) available for pregnenolone and androstane-3,17-diol glucuronide
Article | Year |
---|---|
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |
Profiling Neuroactive Steroid Levels After Traumatic Brain Injury in Male Mice.
Topics: Androstane-3,17-diol; Animals; Brain; Brain Edema; Brain Injuries, Traumatic; Dihydrotestosterone; Male; Mice; Neurotransmitter Agents; Pregnenolone; Progesterone; Random Allocation; Testosterone; Weight Loss | 2016 |